SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Vector1 who wrote (5190)6/22/1998 6:03:00 PM
From: Rocketman  Read Replies (1) of 9719
 
From Motley Fool News: Genzyme Corp. (Nasdaq:GENZ - news) dropped $1
3/16 to $23 13/16 after Furman Selz downgraded the biotechnology and healthcare products company to "hold" from "buy". GEEZ, the PE is a whopping 24, what a steal.

What a mess this market is in. How long do you figure the biotech bear to continue playing havoc???

We should have cleaned out the margin debt entirely, if not raised some cash when our asset level was at $130K and you saw the bear coming. Seems like we do better trading than investing long. Especially since there are no tax consequences.

Man is the ENMD board on Yahoo offensive. I want this stock to tank just to put it to the idiots there, let alone make $ on the short. What would you think about only covering half the shorted ENMD tomorrow? I really think this is still a balloon, and I seriously doubt they have much new news to give at the meeting. I don't think these hypesters could withhold news long enough to save it for the meeting.

Rman
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext